QNRX

Quoin Pharmaceuticals Ltd

• TipRanks·03/28 06:00

  Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays

• Benzinga·03/27 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• TipRanks·03/27 11:06

  Quoin Pharmaceuticals price target raised to $35 from $25 at Alliance Global

• TipRanks·03/26 12:50

  Analysts Offer Insights on Healthcare Companies: Journey Medical Corp (DERM), Quoin Pharmaceuticals (QNRX) and SeaStar Medical Holding (ICU)

• Seeking Alpha·03/26 12:32

  Quoin Pharmaceuticals GAAP EPS of -$1.74 beats by $2.28

• Benzinga·03/26 12:32

  Quoin Pharmaceuticals Q4 EPS $(1.74) Beats $(4.02) Estimate

• Benzinga·03/26 11:11

  Earnings Scheduled For March 26, 2026

• NASDAQ·03/26 06:22

  Quoin Updates On Type C Meet With FDA For QRX003 In NS; On Track To Initiate Phase 3 Trial In 2026

• TipRanks·03/25 13:40

  Quoin Pharmaceuticals Ltd – ADR trading resumes

• TipRanks·03/25 13:35

  Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause

• TipRanks·03/25 12:55

  Quoin Pharmaceuticals provides update following QRX003 Type C meeting with FDA

• Benzinga·03/25 12:39

  Quoin Pharma Provides Clinical And Regulatory Update From Recent Constructive Type C Meeting With FDA For QRX003, For Treatment Of Netherton Syndrome

• TipRanks·03/12 01:10

  Quoin Wins FDA Fast Track for QRX003 in Netherton

• Benzinga·03/11 12:41

  Quoin Pharmaceuticals Receives FDA's Fast Track Designation To QRX003 Lotion To Treat Netherton Syndrome

• TipRanks·03/06 13:25

  Maxim Group Sticks to Its Buy Rating for Quoin Pharmaceuticals (QNRX)